Favipiravir: az ígéretes koronavírus elleni szer, amiből betáraztunk | EgészségKalauz
Favipiravir - Wikipedia
Citation needed? Wikipedia and the COVID-19 pandemic | bioRxiv
Frontiers | Perspectives About Modulating Host Immune System in Targeting SARS-CoV-2 in India
Favipiravir - Wikipedia
Favipiravir - Wikipedia
Coronavirus Disease 2019 (COVID-19): A Global Crisis
COVID-19 - Wikidata
The Pipette Gazette » Current progress and challenges of drug development in COVID-19
Soloxolone methyl inhibits influenza virus replication and reduces virus-induced lung inflammation | Scientific Reports
Ebola outbreak: Japan offers anti-influenza drug for treatment | CBC News
Drug regulator approves Favipiravir for mild to moderate cases of COVID-19 - The Week
SARS‐COV‐2 (COVID‐19): Cellular and biochemical properties and pharmacological insights into new therapeutic developments - Parlakpinar - 2021 - Cell Biochemistry and Function - Wiley Online Library
Favipiravir, lopinavir-ritonavir, or combination therapy (FLARE): A randomised, double-blind, 2 × 2 factorial placebo-controlled trial of early antiviral therapy in COVID-19 | PLOS Medicine
Drug Combinations as a First Line of Defense against Coronaviruses and Other Emerging Viruses | mBio
Favipiravir - Wikipedia
Antiviral properties of placental growth factors: A novel therapeutic approach for COVID-19 treatment - ScienceDirect
File:Favipiravir-RTP structure.png - Wikimedia Commons
favipiravir | C5H4FN3O2 | ChemSpider
FabiFlu: All you need to know about Glenmark's COVID-19 treatment medicine | Glenmark News – India TV
Favipiravir, an anti-influenza drug against life-threatening RNA virus infections. - Abstract - Europe PMC
Drug regulator approves Favipiravir for mild to moderate cases of COVID-19 - The Week
Citation needed? Wikipedia bibliometrics during the first wave of the COVID-19 pandemic | bioRxiv
